Mesothelioma: Peritoneal, Version 2.2023

David S. Ettinger; Douglas E. Wood; James Stevenson; Dara L. Aisner; Wallace Akerley; Jessica R. Bauman; Ankit Bharat; Debora S. Bruno; Joe Y. Chang; Lucian R. Chirieac; Malcolm DeCamp; Thomas J. Dilling; Jonathan Dowell; Gregory A. Durm; Scott Gettinger; Travis E. Grotz; Matthew A. Gubens; Aparna Hegde; Rudy P. Lackner; Michael Lanuti; Jules Lin; Billy W. Loo; Christine M. Lovly; Fabien Maldonado; Erminia Massarelli; Daniel Morgensztern; Trey C. Mullikin; Thomas Ng; Gregory A. Otterson; Sandip P. Patel; Tejas Patil; Patricio M. Polanco; Gregory J. Riely; Jonathan Riess; Theresa A. Shapiro; Aditi P. Singh; Alda Tam; Tawee Tanvetyanon; Jane Yanagawa; Stephen C. Yang; Edwin Yau; Kristina M. Gregory; Miranda Hughes

doi:10.6004/jnccn.2023.0045

Mesothelioma: Peritoneal, Version 2.2023

David S. Ettinger, Douglas E. Wood, James Stevenson, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael LanutiJules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes

Research output: Contribution to journal › Article › peer-review

Abstract

Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term “malignant” is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.

Original language	English (US)
Pages (from-to)	961-979
Number of pages	19
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2023.0045
State	Published - Sep 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.0045

Cite this

Ettinger, D. S., Wood, D. E., Stevenson, J., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P., ... Hughes, M. (2023). Mesothelioma: Peritoneal, Version 2.2023. JNCCN Journal of the National Comprehensive Cancer Network, 21(9), 961-979. https://doi.org/10.6004/jnccn.2023.0045

Ettinger, DS, Wood, DE, Stevenson, J, Aisner, DL, Akerley, W, Bauman, JR, Bharat, A, Bruno, DS, Chang, JY, Chirieac, LR, DeCamp, M, Dilling, TJ, Dowell, J, Durm, GA, Gettinger, S, Grotz, TE, Gubens, MA, Hegde, A, Lackner, RP, Lanuti, M, Lin, J, Loo, BW, Lovly, CM, Maldonado, F, Massarelli, E, Morgensztern, D, Mullikin, TC, Ng, T, Otterson, GA, Patel, SP, Patil, T, Polanco, PM, Riely, GJ, Riess, J, Shapiro, TA, Singh, AP, Tam, A, Tanvetyanon, T, Yanagawa, J, Yang, SC, Yau, E, Gregory, KM & Hughes, M 2023, 'Mesothelioma: Peritoneal, Version 2.2023', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 9, pp. 961-979. https://doi.org/10.6004/jnccn.2023.0045

@article{996aab10f3b54a3c840a133d180b9c77,

title = "Mesothelioma: Peritoneal, Version 2.2023",

abstract = "Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term “malignant” is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.",

author = "Ettinger, {David S.} and Wood, {Douglas E.} and James Stevenson and Aisner, {Dara L.} and Wallace Akerley and Bauman, {Jessica R.} and Ankit Bharat and Bruno, {Debora S.} and Chang, {Joe Y.} and Chirieac, {Lucian R.} and Malcolm DeCamp and Dilling, {Thomas J.} and Jonathan Dowell and Durm, {Gregory A.} and Scott Gettinger and Grotz, {Travis E.} and Gubens, {Matthew A.} and Aparna Hegde and Lackner, {Rudy P.} and Michael Lanuti and Jules Lin and Loo, {Billy W.} and Lovly, {Christine M.} and Fabien Maldonado and Erminia Massarelli and Daniel Morgensztern and Mullikin, {Trey C.} and Thomas Ng and Otterson, {Gregory A.} and Patel, {Sandip P.} and Tejas Patil and Polanco, {Patricio M.} and Riely, {Gregory J.} and Jonathan Riess and Shapiro, {Theresa A.} and Singh, {Aditi P.} and Alda Tam and Tawee Tanvetyanon and Jane Yanagawa and Yang, {Stephen C.} and Edwin Yau and Gregory, {Kristina M.} and Miranda Hughes",

year = "2023",

month = sep,

doi = "10.6004/jnccn.2023.0045",

language = "English (US)",

volume = "21",

pages = "961--979",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "9",

}

TY - JOUR

T1 - Mesothelioma

T2 - Peritoneal, Version 2.2023

AU - Ettinger, David S.

AU - Wood, Douglas E.

AU - Stevenson, James

AU - Aisner, Dara L.

AU - Akerley, Wallace

AU - Bauman, Jessica R.

AU - Bharat, Ankit

AU - Bruno, Debora S.

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - DeCamp, Malcolm

AU - Dilling, Thomas J.

AU - Dowell, Jonathan

AU - Durm, Gregory A.

AU - Gettinger, Scott

AU - Grotz, Travis E.

AU - Gubens, Matthew A.

AU - Hegde, Aparna

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Lin, Jules

AU - Loo, Billy W.

AU - Lovly, Christine M.

AU - Maldonado, Fabien

AU - Massarelli, Erminia

AU - Morgensztern, Daniel

AU - Mullikin, Trey C.

AU - Ng, Thomas

AU - Otterson, Gregory A.

AU - Patel, Sandip P.

AU - Patil, Tejas

AU - Polanco, Patricio M.

AU - Riely, Gregory J.

AU - Riess, Jonathan

AU - Shapiro, Theresa A.

AU - Singh, Aditi P.

AU - Tam, Alda

AU - Tanvetyanon, Tawee

AU - Yanagawa, Jane

AU - Yang, Stephen C.

AU - Yau, Edwin

AU - Gregory, Kristina M.

AU - Hughes, Miranda

PY - 2023/9

Y1 - 2023/9

N2 - Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term “malignant” is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.

AB - Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term “malignant” is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.

UR - http://www.scopus.com/inward/record.url?scp=85169998638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169998638&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.0045

DO - 10.6004/jnccn.2023.0045

M3 - Article

C2 - 37673108

AN - SCOPUS:85169998638

SN - 1540-1405

VL - 21

SP - 961

EP - 979

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Mesothelioma: Peritoneal, Version 2.2023

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this